- 1. Tanimura Y, Aoi W, Mizushima K, Higashimura Y, Naito Y. Combined treatment of dipeptidyl peptidase‐4 inhibitor and exercise training improves lipid profile in KK/Ta mice. Experimental Physiology. 2019;104(7):1051-60.
- 2. Abednatanzi H, Gholami M. Study of liver damage from mir-423-5p and Akt2-FAM3a pathway HIIT and royal jelly in type 2 diabetic rats. Iranian Journal of Diabetes and Metabolism. 2024;24(1):34-46. [In persian]
- 3. Tayebi SM, Saeidi A, Shahghasi R, Golmohammadi M. The eight-week circuit resistance training decreased the serum levels of WISP-1 and WISP-2 in individuals with type 2 diabetes. Annals of Applied Sport Science. 2023;11(4):1-9. [In persian]
- 4. Daniele G, Guardado Mendoza R, Winnier D, Fiorentino T, Pengou Z, Cornell J, et al. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta diabetologica. 2014;51:123-31.
- 5. Falcao-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenco AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug discovery today. 2012;17(15-16):880-9.
- 6. Blüher M. Adipokines–removing road blocks to obesity and diabetes therapy. Molecular metabolism. 2014;3(3):230-240
- 7. Bahreini A, Fathi R. Comparing the Effect of eight weeks of interval and continuous aAerobic training on serum levels of WISP1 and TNF-αin overweight/0bese girls. Journal of Sports and Biomotor Sciences. 2017;9(18):1-12. [In persian]
- 8. Bahador H, Taghian F. The effect of 8 weeks interval exercises and vitamin D supplementation on plasma levels of dipeptidyl peptidase-4 and retinol binding protein 4 in overweight women. 2019;21(2): 73-82. [In persian]
- 9. Malin SK, Huang H, Mulya A, Kashyap SR, Kirwan JP. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome. Peptides. 2013;47:142-7.
- 10. Raschke S, Eckardt K, Bjørklund Holven K, Jensen J, Eckel J. Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PloS one. 2013;8(4):e62008.
- 11. Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes care. 2007;30(6):1335-1345
- 12. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60(7):1917-25.
- 13. Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, et al. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proceedings of the National Academy of Sciences. 2003;100(11):6825-30.
- 14. Baumeier C, Saussenthaler S, Kammel A, Jähnert M, Schlüter L, Hesse D, et al. Hepatic DPP4 DNA methylation associates with fatty liver. Diabetes. 2017;66(1):25-35.
- 15. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature reviews immunology. 2011;11(2):85-97.
- 16. Murahovschi V, Pivovarova O, Ilkavets I, Dmitrieva RM, Döcke S, Keyhani-Nejad F, et al. WISP1 is a novel adipokine linked to inflammation in obesity. Diabetes. 2015;64(3):856-66.
- 17. Fasshauer M, Blüher M. Adipokines in health and disease. Trends in pharmacological sciences. 2015;36(7):461-70.
- 18. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical practice. 2014;105(2):141-50.
- 19. Grünberg JR, Hammarstedt A, Hedjazifar S, Smith U. The novel secreted adipokine WNT1-inducible signaling pathway protein 2 (WISP2) is a mesenchymal cell activator of canonical WNT. Journal of biological chemistry. 2014;289(10):6899-907.
- 20. Kharghani A, Rezaeian N, Yaghoubi A. Effect of aerobic training on serum levels of WISP1 and TNF-α and insulin resistance in obese men with type 2 diabetes. Journal of Applied Exercise Physiology. 2022;18(35):153-64. [In persian]
- 21. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological reviews. 2013.
- 22. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology. 2012;8(8):457-65.
- 23. Chang JS, Kim TH, Kong ID. Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: A randomized controlled trial. Scientific reports. 2020;10(1):10898.
- 24. Ebrahimi A. The effect of moderate-intensity continuous training Vs. high-intensity interval training on visceral and subcutaneous fats in obese women. Journal of Rafsanjan University of Medical Sciences. 2018;16(11):999-1012. [In persian]
- 25. Davies SR, Davies ML, Sanders A, Parr C, Torkington J, Jiang WG. Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. International journal of oncology. 2010;36(5):1129-36.
- 26. Klimontov VV, Bulumbaeva DM, Fazullina ON, Lykov AP, Bgatova NP, Orlov NB, et al. Circulating Wnt1‐inducible signaling pathway protein‐1 (WISP‐1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes. Journal of Cell Communication and Signaling. 2020;14(1):101-9.
- 27. Sahin Ersoy G, Altun Ensari T, Subas S, Giray B, Simsek EE, Cevik O. WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus. The journal of maternal-fetal & neonatal medicine. 2017;30(8):942-6.
- 28. Hörbelt T, Tacke C, Markova M, Herzfeld de Wiza D, Van de Velde F, Bekaert M, et al. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes. Diabetologia. 2018;61:2054-65.
- 29. Tacke C, Aleksandrova K, Rehfeldt M, Murahovschi V, Markova M, Kemper M, et al. Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP‐1)/CCN4 as a novel biomarker of obesity. Journal of cell communication and signaling. 2018;12(3):539-48.
- 30. Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, et al. WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes. Journal of the Endocrine Society. 2017;1(6):660-70.
- 31. Gregg EW, Shaw JE. Global health effects of overweight and obesity. Mass Medical Soc; 2017. p. 80-1.
- 32. Azali A, Gholami F. Effect of aerobic training on retinol binding protein-4 and insulin resistance in women with metabolic syndrome. Metabolism and Exercise A Bioannual Journal. 2015;2016(5):15. [In persian]
- 33. Abbassi-Daloii A, Shaghi R, Ahmadi M, Kohanpour MA. determine the effects of resistance training on serum levels of GLP-1, DPP-4 and insulin resistance in obese men. Journal of Sport and Exercise Physiology. 2017;10(1):21-30. [In persian]
- 34. Rahimi N, Sharif MAS, Goharian AR, Pour AH. The effects of aerobic exercises and 25 (OH) D supplementation on GLP1 and DPP4 level in type II diabetic patients. International Journal of Preventive Medicine. 2017;8(1):56. [In persian]
- 35. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852-7.
|
